Progenics Pharmaceuticals, Inc. (PGNX) Forms $5.35 Double Bottom; 5 Bullish Analysts Covering Bill Barrett (BBG)

Progenics Pharmaceuticals, Inc. (PGNX) formed double bottom with $5.14 target or 4.00% below today’s $5.35 share price. Progenics Pharmaceuticals, Inc. (PGNX) has $375.94 million valuation. The stock decreased 3.43% or $0.19 during the last trading session, reaching $5.35. About 1.17 million shares traded or 5.35% up from the average. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) has risen 48.41% since February 9, 2017 and is uptrending. It has outperformed by 31.71% the S&P500.

Among 19 analysts covering Bill Barrett Corporation (NYSE:BBG), 5 have Buy rating, 2 Sell and 12 Hold. Therefore 26% are positive. Bill Barrett Corporation had 61 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Bill Barrett Corporation (NYSE:BBG) has “Accumulate” rating given on Tuesday, September 29 by Global Hunter Securities. On Thursday, August 11 the stock rating was maintained by Barclays Capital with “Equal-Weight”. As per Monday, June 6, the company rating was maintained by Barclays Capital. The firm earned “Hold” rating on Thursday, December 15 by Wunderlich. Barclays Capital maintained the stock with “Equal-Weight” rating in Wednesday, December 13 report. As per Friday, September 4, the company rating was maintained by BMO Capital Markets. Wunderlich maintained the shares of BBG in report on Friday, June 3 with “Buy” rating. The rating was initiated by JP Morgan on Tuesday, October 13 with “Neutral”. On Wednesday, March 30 the stock rating was downgraded by Canaccord Genuity to “Hold”. BMO Capital Markets maintained Bill Barrett Corporation (NYSE:BBG) on Friday, August 11 with “Hold” rating. See Bill Barrett Corporation (NYSE:BBG) latest ratings:

05/02/2018 Broker: Imperial Capital Rating: Buy New Target: $9.0 Upgrade
13/12/2017 Broker: Barclays Capital Rating: Equal-Weight Old Target: $7 New Target: $6 Maintain
07/12/2017 Broker: Imperial Capital Old Rating: Outperform New Rating: In-Line Downgrade
20/11/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
20/11/2017 Broker: Barclays Capital Rating: Equal-Weight Old Target: $4 New Target: $7 Maintain
14/11/2017 Broker: BMO Capital Markets Rating: Hold New Target: $6.0 Maintain
02/11/2017 Broker: Imperial Capital Rating: Buy New Target: $8.0 Upgrade
16/10/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
10/10/2017 Broker: BMO Capital Markets Rating: Hold New Target: $4.0 Maintain
05/10/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $7.0 Maintain

The stock decreased 2.20% or $0.11 during the last trading session, reaching $4.89. About 4.23M shares traded or 51.75% up from the average. Bill Barrett Corporation (NYSE:BBG) has declined 43.01% since February 9, 2017 and is downtrending. It has underperformed by 59.71% the S&P500.

Since September 8, 2017, it had 0 buys, and 3 sales for $118,700 activity. $46,400 worth of stock was sold by WOODALL R SCOT on Friday, December 15.

Investors sentiment increased to 1.3 in 2017 Q3. Its up 0.13, from 1.17 in 2017Q2. It improved, as 13 investors sold Bill Barrett Corporation shares while 37 reduced holdings. 19 funds opened positions while 46 raised stakes. 60.94 million shares or 5.20% less from 64.29 million shares in 2017Q2 were reported. Federated Incorporated Pa holds 0% or 7,392 shares in its portfolio. New Generation reported 1.10 million shares stake. Texas Permanent School Fund holds 0% of its portfolio in Bill Barrett Corporation (NYSE:BBG) for 55,688 shares. Vanguard Grp Inc Inc owns 0% invested in Bill Barrett Corporation (NYSE:BBG) for 4.71M shares. Schroder Inv Group Incorporated holds 0.01% of its portfolio in Bill Barrett Corporation (NYSE:BBG) for 756,800 shares. Citigroup holds 196 shares. Zurcher Kantonalbank (Zurich Cantonalbank) has 4,829 shares. Victory Mngmt invested in 0% or 146,455 shares. State Of Tennessee Treasury Department accumulated 66,897 shares. Renaissance Technologies Ltd Liability reported 0.02% stake. Virtu Limited Co holds 27,355 shares or 0% of its portfolio. Walleye Trading Limited Company holds 30,457 shares or 0% of its portfolio. Ny State Common Retirement Fund invested in 0% or 51,400 shares. Peak6 Investments Limited Partnership holds 0% or 3,416 shares in its portfolio. Van Den Berg I Incorporated has 0.05% invested in Bill Barrett Corporation (NYSE:BBG).

Bill Barrett Corporation, an independent energy company, acquires, explores for, and develops oil and natural gas resources in the United States. The company has market cap of $539.66 million. It primarily holds interests in the Denver-Julesburg basin and the Uinta oil program in the Uinta Basin in the Rocky Mountain region of the United States. It currently has negative earnings.

Investors sentiment decreased to 1.11 in 2017 Q3. Its down 0.18, from 1.29 in 2017Q2. It dived, as 22 investors sold Progenics Pharmaceuticals, Inc. shares while 34 reduced holdings. 16 funds opened positions while 46 raised stakes. 58.90 million shares or 4.84% less from 61.90 million shares in 2017Q2 were reported. State Of Tennessee Treasury Department accumulated 61,611 shares. Moreover, Ardsley Advisory Ptnrs has 1.87% invested in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) for 1.91 million shares. Bank & Trust Of America Corp De invested in 583,184 shares or 0% of the stock. Moreover, Opus Point Prtn Lc has 0.14% invested in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) for 21,782 shares. 6,763 are held by Riverhead Lc. Tiaa Cref Lc accumulated 0% or 473,884 shares. Moreover, Group One Trading Lp has 0% invested in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Panagora Asset Mngmt holds 0% of its portfolio in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) for 3,581 shares. Parallax Volatility Advisers Lp reported 1,959 shares. Numeric Invsts Lc holds 0.02% or 293,400 shares. Voya Inv Mgmt Limited Liability Corporation stated it has 35,657 shares or 0% of all its holdings. Aperio Grp Inc Incorporated Limited Liability Co invested in 16,069 shares. Blackrock Incorporated stated it has 9.79M shares or 0% of all its holdings. Rice Hall James And Ltd Limited Liability Company owns 0.43% invested in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) for 1.31M shares. Moreover, Sio Limited Liability has 0.34% invested in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) for 88,523 shares.

Among 5 analysts covering Progenics Pharm (NASDAQ:PGNX), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Progenics Pharm had 11 analyst reports since August 6, 2015 according to SRatingsIntel. The stock has “Buy” rating by Zacks on Friday, August 7. On Tuesday, September 26 the stock rating was maintained by Jefferies with “Buy”. The firm earned “Strong Buy” rating on Monday, February 6 by Needham. The firm earned “Buy” rating on Thursday, August 6 by Brean Capital. Needham maintained the shares of PGNX in report on Friday, August 7 with “Buy” rating. The firm has “Buy” rating by Needham given on Tuesday, June 20. The firm has “Buy” rating by Jefferies given on Thursday, June 8. Aegis Capital initiated Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) on Thursday, October 27 with “Buy” rating. The stock of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) earned “Buy” rating by Cantor Fitzgerald on Wednesday, August 9. The company was upgraded on Friday, October 23 by Jefferies.